Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284271
Status:
COMPLETED
Last Update Posted:
2011-07-29
First Post:
2006-01-27
Brief Title:
Feasibility and Efficacy of BACOPP-21 for Patients 60 Years With Intermediate or Advanced Hodgkins Lymphoma
Sponsor:
University of Cologne
Organization:
University of Cologne
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to test 1 feasibility and efficiancy of new BACOPP regimen and 2 toxicity overall response and FFTF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None